Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREZENT: Pancreatic Enzyme Supplementation in Critically Ill Patients
NCT05112328Recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Jul 2021
- Primary completion
- Jul 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of pancreatin in exocrine pancreatic insufficiency (EPI) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Change of Phase angle at 14 days. Started Jul 2021; status: recruiting.
02
Drugs
pancreatin
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT05112328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05112328.